当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cloud-based data systems in drug regulation: an industry perspective.
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2019-11-11 , DOI: 10.1038/d41573-019-00193-7
Andrew S. Robertson , Hilary Malone , Fabio Bisordi , Helen Fitton , Carlos Garner , Stacy Holdsworth , Peter Honig , Mathias Hukkelhoven , Robert Kowalski , Sandra Milligan , Liza O’Dowd , Khyati Roberts , Michelle Rohrer , Jerry Stewart , Mark Taisey , Roopal Thakkar , Karin Van Baelen , Max Wegner

Cloud-based systems for data submitted by sponsors to drug regulatory agencies have the potential to accelerate drug development, streamline regulatory review and enhance regulatory decision-making. Here, we provide a vision for integrating cloud-enabled practices in drug regulation globally.

中文翻译:

药品监管中基于云的数据系统:行业观点。

发起人向药品监管机构提交的基于云的数据系统有可能加速药品开发,简化监管审查并增强监管决策。在这里,我们提供了将全球支持云的实践整合到全球药品监管中的愿景。
更新日期:2019-11-11
down
wechat
bug